News Updates
The secret to slimming? Special 'skinny genes' double weight loss
The secret to losing weight could all be down to a combination of 14 "skinny genes," a new study has found.
Teens who had bariatric surgery maintain weight loss, diabetes remission 10 years later
A decade after receiving gastric bypass or sleeve gastrectomy as adolescents, many people maintain their weight loss and achieve remission of obesity-related conditions, including diabetes, according to a study.
Bariatric surgery found to be more cost effective than newer weight loss drugs alone
Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according to a study presented at the American College of Surgeons (ACS) Clinical Congress 2024 in San Francisco, California.
Prenatal ozone: A silent culprit in the battle against childhood obesity
Air pollution, particularly ozone exposure, has recently been identified as a potential risk factor for obesity and metabolic disorders.
Defining obesity is complex, because it depends on who you are
In two new papers published in Annals of Internal Medicine, social justice and obesity experts weigh in on the Body Mass Index and discuss its advantages and challenges as a measure of obesity, particularly in different racial and ethnic groups, and how this influences perceptions and patient care.
Gastric bypass for obesity lowers major atherogenic blood lipids vs. very low-energy diet
Roux-en-Y gastric bypass reduced atherogenic blood lipids at 6 weeks, while lipids remained stable with a very low-energy diet.
Trying to limit calories? Skip the dip, researchers advise
The chips and dip together yielded a 77% greater caloric intake, and a faster total eating rate compared to the "just chips, no-dip" control.
Weight loss linked to improved mood and reduced risk-taking in obese individuals
People who are severely overweight (obese) not only exhibit altered risk behavior, but also changes in their metabolism and psyche.
Diabetes and obesity can cause liver failure—but few people know their risk of developing liver disease
Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a buildup of fat in the liver. Formerly known as nonalcoholic fatty liver disease, this condition affects 1 in 4 people worldwide. Among those with type 2 diabetes, insulin resistance, obesity or all three, the prevalence of MASLD increases to 3 in 4 people.
Children from less affluent families are less active, have poorer diets and suffer from obesity, says report
A new report released by the WHO Regional Office for Europe reveals alarming disparities in the health of young people across the region, with those from less affluent families disproportionately affected.